Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models. Founded by C. Geoffrey Davis, Jeffrey Port, John Klacking, and Shahin Rafii in 2012, Angiocrine Bioscience is headquartered in New York.